The present invention relates to pharmaceutical formulations for a therapeutical antibody, preferably an IgG, said formulation comprising at least acetate/acidic acid, arginine, and trehalose. In addition, the present invention relates to pharmaceutical formulations for a therapeutical antibody, preferably an IgG, said formulation comprising at least histidine, mannitol and/or succinate and trehalose.